About
Get in Touch Request a Quote

Life Sciences Market Research in South Africa

Data-driven insights to navigate the life sciences sector with confidence.

Request a quote

Life Sciences Market Research

Life sciences covers a broader waterfront than pharma or biotech alone — diagnostics, tools, instruments, CROs, CDMOs and research infrastructure all live here, and each has distinct research needs. Meraki Research works across the life-sciences value chain for commercial, investor and policy clients in South Africa and internationally.

Why Life Sciences Research Matters

  • Life-sciences tools and instruments markets have long procurement cycles, academic purchasing patterns and grant-linked funding dynamics that require specific methodological handling.
  • CRO and CDMO selection is increasingly a strategic rather than tactical decision — research has to reflect that elevation.
  • Academic and government research buyers behave very differently from commercial laboratory buyers.
  • South African life-sciences infrastructure — including the SAMRC, NHLS, CSIR and university networks — shapes both demand and supply in ways international research misses.
  • POPIA and the Protection of Personal Information of Research Participants protocols shape what primary research is permissible in and with research institutions.

Our Life Sciences Research Services

Instrument and Consumables Research

Research into laboratory instrument selection, consumables switching and the full lifetime economics of equipment purchases.

CRO and CDMO Market Research

Research into CRO and CDMO selection criteria, performance expectations and switching dynamics from the sponsor perspective.

Academic and Grant-Funded Buyer Research

Specialised research into academic and publicly funded research-buyer behaviour, including grant-cycle effects on purchasing.

Diagnostics and Testing Research

Research into diagnostic adoption, including the interplay between public-sector testing (NHLS) and private-sector laboratories.

Research Infrastructure Policy

Research for policy clients on the state of research infrastructure and human capital across South Africa and the continent.

Industry Investor Research

Investor-grade research covering specific life-sciences segments, growth drivers and geographic opportunity.

How We Approach Research in This Sector

Life-sciences research requires sector-literate researchers and a patient approach to long procurement cycles and small, networked audiences. We treat academic and commercial buyers as separate populations with distinct decision frameworks, and we build research designs that reflect grant-cycle and fiscal-year dynamics rather than generic enterprise purchasing assumptions.

Why Choose Meraki Research for Life Sciences?

  • Researchers with life-sciences sector experience, including past roles in instruments, CROs and research institutions.
  • Strong access to South African academic and research institution audiences.
  • Understanding of the SA and broader African life-sciences infrastructure and funding landscape.
  • Investor-grade rigour and discipline across due diligence and market research engagements.

What We Deliver

DeliverableFormatTypical Timeline
Buyer Research ReportPDF + clip libraryWeek 5
Competitive and Segment LandscapeSlide deck + matrixWeek 6
Pricing and Commercial BriefingPDF + workbookWeek 7
Policy and Infrastructure BriefingPDF reportWeek 8
Quarterly TrackerDashboard + commentaryOngoing

Frequently asked questions

Yes, as distinct audiences. Methodologies differ — academic work respects grant cycles and institutional hierarchies, commercial work uses standard B2B frameworks.

Yes — CRO and CDMO research is a core engagement type, covering selection, performance, switching and capacity dynamics.

With specific attention to the additional obligations around research participant information. We work within institutional ethics and data-handling protocols wherever relevant.

Yes, both buy-side and operating-company clients. Due-diligence work is scoped carefully to deliver within tight transaction timelines.

Yes — we work with DSI, the SAMRC, universities and international bodies on research infrastructure and human capital work.

Life Sciences Market Research in South Africa — Meraki’s Perspective

SA life sciences covers pharmaceutical manufacturers and distributors (Aspen, Adcock Ingram, Cipla Medpro, Pharma Dynamics), medical-device companies, diagnostics specialists (Abbott, Roche, PathCare, Ampath, Lancet), and a growing bio-tech and translational-research layer linked to academic medical centres. Regulation under SAHPRA (registration, clinical trials, GMP), medical-scheme formulary processes, and state procurement via central-tender all shape commercial outcomes. Meraki's life-sciences research covers HCP therapy-area studies (specialist and GP, multi-specialty networks), patient-experience and adherence research, market-access studies with scheme and state buyers, brand-positioning work in competitive therapy areas, and new-product concept testing. We run clinical-trial patient-recruitment and site-satisfaction research. Our teams understand the MCC-to-SAHPRA transition realities, the intricacies of medical-scheme benefit design, and the dual-track public-private market-access path. Evidence for decisions with patient-outcome consequences.

Ready to Explore the Life Sciences Market?

Let’s design a research programme that delivers the intelligence your organisation needs.

Industries We Research